Corteva (NYSE:CTVA) Issues Earnings Results, Beats Estimates By $0.04 EPS

Corteva (NYSE:CTVA) issued its earnings results on Wednesday. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.02 by $0.04, Briefing.com reports. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.77 billion. During the same quarter last year, the company earned ($0.23) EPS. The firm’s revenue was down 8.7% compared to the same quarter last year. Corteva updated its FY 2026 guidance to 0.760-0.800 EPS.

Corteva Trading Up 0.2%

Shares of CTVA opened at $12.20 on Thursday. The firm’s 50-day moving average price is $40.43 and its 200-day moving average price is $70.20. The firm has a market capitalization of $8.14 billion, a price-to-earnings ratio of 8.08, a PEG ratio of 1.70 and a beta of 0.58. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva has a 1-year low of $11.24 and a 1-year high of $90.97.

Corteva Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Tuesday, December 1st will be given a $0.05 dividend. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $0.20 annualized dividend and a dividend yield of 1.6%. This is a negative change from Corteva’s previous quarterly dividend of $0.18. Corteva’s dividend payout ratio is 47.68%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on CTVA. Oppenheimer set a $17.00 price objective on Corteva in a report on Monday, October 5th. The Goldman Sachs Group restated a “buy” rating and set a $20.00 price target on shares of Corteva in a research report on Thursday, October 8th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $17.00 price target on shares of Corteva in a research note on Wednesday, October 7th. Morgan Stanley reaffirmed an “overweight” rating and issued a $18.00 price target on shares of Corteva in a research note on Friday, October 2nd. Finally, Argus reiterated a “buy” rating and issued a $91.00 price objective on shares of Corteva in a research report on Friday, September 18th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $60.59.

Corteva Company Profile

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.